Quantitative assessment and classification of tissue-based biomarker expression with color content analysis.
暂无分享,去创建一个
[1] E. Frenkel,et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. , 2001, American journal of clinical pathology.
[2] Dorin Comaniciu,et al. Image-guided decision support system for pathology , 1999, Machine Vision and Applications.
[3] James C. Bezdek,et al. Pattern Recognition with Fuzzy Objective Function Algorithms , 1981, Advanced Applications in Pattern Recognition.
[4] J. Doroshow. Targeting EGFR in non-small-cell lung cancer. , 2005, The New England journal of medicine.
[5] Paul Scheunders,et al. A genetic c-Means clustering algorithm applied to color image quantization , 1997, Pattern Recognit..
[6] R. Walker,et al. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment I , 2006, Histopathology.
[7] W. McGuire,et al. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Marilyn M. Bui,et al. Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it? , 2010, Journal of pathology informatics.
[9] J. Papadimitriou,et al. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium. , 2001, Archives of pathology & laboratory medicine.
[10] Klaus Kayser,et al. Quantification of virtual slides: Approaches to analysis of content-based image information , 2011, Journal of pathology informatics.
[11] Ioannis Pitas,et al. Color-based descriptors for image fingerprinting , 2006, IEEE Transactions on Multimedia.
[12] R. Steele,et al. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer , 2006, Modern Pathology.
[13] H A Lehr,et al. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. , 2001, American journal of clinical pathology.
[14] M. Duffy,et al. Objective measurement of breast cancer oestrogen receptor status through digital image analysis. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] Jiang Gu,et al. Virtual microscopy and virtual slides in teaching, diagnosis, and research , 2005 .
[16] J. Bartlett,et al. The clinical evaluation of HER‐2 status: which test to use? , 2003, The Journal of pathology.
[17] Qiang Wu,et al. Microscope Image Processing , 2010 .
[18] I Vergote,et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. , 1997, Journal of clinical pathology.
[19] R. Henderson,et al. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer. , 1993, American journal of clinical pathology.
[20] Alexis B. Carter,et al. HIMSS10 – Perspectives from a newcomer pathologist and a seasoned attendee pathologist: Pathologists should attend! , 2010, Journal of pathology informatics.
[21] M. Dowsett,et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. , 2005, The New England journal of medicine.
[22] D. Larsimont,et al. Evaluation of HER-2/NEU Protein Expression in Breast Cancer by Immunohistochemistry: An Interlaboratory Study Assessing the Reproducibility of HER-2/NEU Testing , 2002, Breast Cancer Research and Treatment.
[23] A. Dc,et al. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer , 1993 .
[24] D S Weinberg,et al. Color images in telepathology: how many colors do we need? , 1997, Human pathology.
[25] Georgios Tziritas,et al. Face Detection Using Quantized Skin Color Regions Merging and Wavelet Packet Analysis , 1999, IEEE Trans. Multim..
[26] Youli Zu,et al. Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma , 2005, Leukemia & lymphoma.
[27] K. Bloom,et al. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. , 2004, American journal of clinical pathology.
[28] D. Allred,et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study , 2004, Modern Pathology.
[29] S. Lakhani,et al. Current and future approach to the pathologist's assessment for targeted therapy in breast cancer , 2009, Pathology.
[30] A. Kak,et al. Automated storage and retrieval of thin-section CT images to assist diagnosis: system description and preliminary assessment. , 2003, Radiology.
[31] Lei Zheng,et al. Design and analysis of a content-based pathology image retrieval system , 2003, IEEE Transactions on Information Technology in Biomedicine.
[32] Peng Gao,et al. Application of fuzzy c-means clustering in data analysis of metabolomics. , 2009, Analytical chemistry.
[33] Thomas Rüdiger,et al. Inter‐laboratory and inter‐observer reproducibility of immunohistochemical assessment of the Ki‐67 labelling index in a large multi‐centre trial , 2002, The Journal of pathology.
[34] David L Rimm,et al. Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma , 2004, Cancer Research.
[35] Kyle J. Myers,et al. Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer , 2009, IEEE Transactions on Medical Imaging.
[36] A. Chott,et al. Effect of formalin tissue fixation and processing on immunohistochemistry. , 2000, The American journal of surgical pathology.
[37] Robert Pinard,et al. Development of an Unsupervised Pixel-based Clustering Algorithm for Compartmentalization of Immunohistochemical Expression Using Automated QUantitative Analysis , 2009, Applied immunohistochemistry & molecular morphology : AIMM.
[38] J. Baak,et al. Prognostic value of proliferation in invasive breast cancer: a review , 2004, Journal of Clinical Pathology.
[39] K. Edmiston,et al. HER-2 Status in Breast Cancer: Correlation of Gene Amplification by FISH With Immunohistochemistry Expression Using Advanced Cellular Imaging System , 2006, Applied immunohistochemistry & molecular morphology : AIMM.
[40] H. Tsuda,et al. Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis , 2001, Pathology international.
[41] Kristine A. Erps,et al. Overview of telepathology, virtual microscopy, and whole slide imaging: prospects for the future. , 2009, Human pathology.
[42] John R. Mackey,et al. Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study. , 2009 .
[43] D. Lubeck,et al. Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer , 2007, Cancer.
[44] Jorma Isola,et al. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. , 2006, The New England journal of medicine.
[45] Anne Vincent-Salomon,et al. High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study. , 2006, European journal of cancer.
[46] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[47] Nikolaos G. Bourbakis,et al. A survey of skin-color modeling and detection methods , 2007, Pattern Recognit..
[48] Mitch Dowsett,et al. Proliferation marker Ki-67 in early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] C. Osborne,et al. Steroid hormone receptors in breast cancer management , 2004, Breast Cancer Research and Treatment.
[50] J. Epstein,et al. Static image analysis of skin specimens: the application of telepathology to frozen section evaluation. , 1997, Human pathology.
[51] L. Holmberg,et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. , 1996, Journal of the National Cancer Institute.
[52] T. Aas,et al. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients , 1996, Nature Medicine.
[53] Aldo Badano,et al. Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy. , 2011, Archives of pathology & laboratory medicine.
[54] T. Kuopio,et al. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints. , 2005, Anticancer research.
[55] M. Kendall. Rank Correlation Methods , 1949 .
[56] G. Barosi,et al. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] Michael T. Orchard,et al. Color quantization of images , 1991, IEEE Trans. Signal Process..
[58] Eric Ziegl,et al. Statistical Methods for the Analysis of Biomedical Data , 1989 .
[59] Adhemar Longatto-Filho,et al. Computer-assisted Immunohistochemical Analysis of Cervical Cancer Biomarkers Using Low-cost and Simple Software , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[60] Greg Yothers,et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.
[61] A Böcking,et al. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer. , 1996, Anticancer research.
[62] B. Molnár,et al. Digital slide and virtual microscopy based routine and telepathology evaluation of routine gastrointestinal biopsy specimens , 2003 .
[63] D. Rimm,et al. Immunohistochemistry and quantitative analysis of protein expression. , 2009, Archives of pathology & laboratory medicine.
[64] Yukako Yagi,et al. Primary histologic diagnosis using automated whole slide imaging: a validation study , 2006, BMC clinical pathology.
[65] T. Seidal,et al. Interpretation and Quantification of Immunostains , 2001, The American journal of surgical pathology.
[66] Ronald S Weinstein,et al. Innovations in medical imaging and virtual microscopy. , 2005, Human pathology.
[67] John J Spinelli,et al. HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization , 2001, Modern Pathology.
[68] O. Kallioniemi,et al. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry , 1990, Cancer.
[69] Stephen M Hewitt,et al. Tissue microarrays: bridging the gap between research and the clinic , 2005, Expert review of proteomics.
[70] K A Matkowskyj,et al. Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Using Commercially Available Software Photoshop and Matlab , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[71] S. Kvaløy,et al. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[72] R M Levenson,et al. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II , 2006, Histopathology.
[73] Antoine Geissbühler,et al. A Review of Content{Based Image Retrieval Systems in Medical Applications { Clinical Bene(cid:12)ts and Future Directions , 2022 .
[74] C. Floyd,et al. Evaluation of information-theoretic similarity measures for content-based retrieval and detection of masses in mammograms. , 2006, Medical physics.
[75] T Vrekoussis,et al. Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. , 2009, Anticancer research.